ID S26A5_MERUN Reviewed; 744 AA. AC Q9JKQ2; DT 27-MAR-2002, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-2000, sequence version 1. DT 13-SEP-2023, entry version 100. DE RecName: Full=Prestin {ECO:0000303|PubMed:10821263}; DE AltName: Full=Solute carrier family 26 member 5; GN Name=SLC26A5 {ECO:0000250|UniProtKB:P58743}; Synonyms=PRES; OS Meriones unguiculatus (Mongolian jird) (Gerbillus unguiculatus). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Gerbillinae; Meriones. OX NCBI_TaxID=10047; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND DEVELOPMENTAL RP STAGE. RC TISSUE=Organ of Corti; RX PubMed=10821263; DOI=10.1038/35012009; RA Zheng J., Shen W., He D.Z.Z., Long K.B., Madison L.D., Dallos P.; RT "Prestin is the motor protein of cochlear outer hair cells."; RL Nature 405:149-155(2000). RN [2] RP TOPOLOGY, AND SUBCELLULAR LOCATION. RX PubMed=11435925; DOI=10.1097/00001756-200107030-00032; RA Zheng J., Long K.B., Shen W., Madison L.D., Dallos P.; RT "Prestin topology: localization of protein epitopes in relation to the RT plasma membrane."; RL NeuroReport 12:1929-1935(2001). RN [3] RP FUNCTION, AND MOTIF. RX PubMed=22399806; DOI=10.1242/jcs.097337; RA Tan X., Pecka J.L., Tang J., Lovas S., Beisel K.W., He D.Z.; RT "A motif of eleven amino acids is a structural adaptation that facilitates RT motor capability of eutherian prestin."; RL J. Cell Sci. 125:1039-1047(2012). RN [4] {ECO:0007744|PDB:7SUN} RP STRUCTURE BY ELECTRON MICROSCOPY (3.60 ANGSTROMS) IN COMPLEX, TOPOLOGY, RP SUBUNIT, MUTAGENESIS OF SER-398 AND ARG-399, DOMAIN, AND FUNCTION. RX PubMed=35022426; DOI=10.1038/s41467-021-27915-z; RA Butan C., Song Q., Bai J.P., Tan W.J.T., Navaratnam D., Santos-Sacchi J.; RT "Single particle cryo-EM structure of the outer hair cell motor protein RT prestin."; RL Nat. Commun. 13:290-290(2022). CC -!- FUNCTION: Voltage-sensitive motor protein that drives outer hair cell CC (OHC) electromotility (eM) and participates in sound amplification in CC the hearing organ (PubMed:10821263, PubMed:22399806). Converts changes CC in the transmembrane electric potential into mechanical displacements CC resulting in the coupling of its expansion to movement of a charged CC voltage sensor across the lipid membrane (PubMed:10821263, CC PubMed:22399806). The nature of the voltage sensor is not completely CC clear, and two models compete. In the first model, acts as an CC incomplete transporter where intracellular chloride anion acts as CC extrinsic voltage sensor that drives conformational change in the CC protein which is sufficient to produce a length change in the plane of CC the membrane and hence in the length of the OHC (By similarity). The CC second model in which multiple charged amino acid residues are CC distributed at the intracellular and extracellular membrane interfaces CC that form an intrinsic voltage sensor, whose movement produces the non- CC linear capacitance (NLC) (PubMed:35022426). However, the effective CC voltage sensor may be the result of a hybrid voltage sensor assembled CC from intrinsic charge (charged residues) and extrinsic charge (bound CC anion) (By similarity). Notably, binding of anions to the anion-binding CC pocket partially neutralizes the intrinsic positive charge rather than CC to form an electrically negative sensor, therefore remaining charge may CC serve as voltage sensor that, after depolarization, moves from down CC (expanded state) to up (contracted) conformation, which is accompanied CC by an eccentric contraction of the intermembrane cross-sectional area CC of the protein as well as a major increase in the hydrophobic thickness CC of the protein having as consequences the plasma membrane thickening CC and the cell contraction after membrane depolarization (By similarity). CC The anion-binding pocket transits from the inward-open (Down) state, CC where it is exposed toward the intracellular solvent in the absence of CC anion, to the occluded (Up) state upon anion binding (By similarity). CC Salicylate competes for the anion-binding site and inhibits the CC voltage-sensor movement, and therefore inhibits the charge transfer and CC electromotility by displacing Cl(-) from the anion-binding site and by CC preventing the structural transitions to the contracted state CC (PubMed:35022426). In addition, can act as a weak Cl(-)/HCO3 (-) CC antiporter across the cell membrane and so regulate the intracellular CC pH of the outer hair cells (OHCs), while firstly found as being unable CC to mediate electrogenic anion transport (By similarity). Moreover, CC supports a role in cardiac mechanical amplification serving as an CC elastic element to enhance the actomyosin- based sarcomere contraction CC system (By similarity). {ECO:0000250|UniProtKB:D7PC76, CC ECO:0000250|UniProtKB:P58743, ECO:0000250|UniProtKB:Q99NH7, CC ECO:0000250|UniProtKB:Q9EPH0, ECO:0000269|PubMed:10821263, CC ECO:0000269|PubMed:22399806, ECO:0000269|PubMed:35022426}. CC -!- CATALYTIC ACTIVITY: CC Reaction=chloride(out) + 2 hydrogencarbonate(in) = chloride(in) + 2 CC hydrogencarbonate(out); Xref=Rhea:RHEA:72207, ChEBI:CHEBI:17544, CC ChEBI:CHEBI:17996; Evidence={ECO:0000250|UniProtKB:Q9EPH0}; CC -!- SUBUNIT: Homodimer (PubMed:35022426). Interacts (via STAS domain) with CC CALM; this interaction is calcium-dependent and the STAS domain CC interacts with only one lobe of CALM which is an elongated conformation CC (By similarity). {ECO:0000250|UniProtKB:A0FKN5, CC ECO:0000250|UniProtKB:Q9EPH0, ECO:0000269|PubMed:35022426}. CC -!- SUBCELLULAR LOCATION: Lateral cell membrane CC {ECO:0000269|PubMed:11435925}; Multi-pass membrane protein CC {ECO:0000269|PubMed:35022426}. Note=Lateral cell membrane of outer hair CC cells (PubMed:11435925). Alters profoundly the shape of its surrounding CC lipid bilayer (By similarity). {ECO:0000250|UniProtKB:P58743, CC ECO:0000269|PubMed:11435925}. CC -!- TISSUE SPECIFICITY: Highly expressed in mature outer hair cells, but CC not in inner hair cells or other cells of the basilar membrane and the CC organ of Corti. {ECO:0000269|PubMed:10821263}. CC -!- DEVELOPMENTAL STAGE: Detected in the organ of Corti as early as 6 days CC after birth; levels increase up to day 20, concomitant with the CC development of high sensitivity hearing. {ECO:0000269|PubMed:10821263}. CC -!- DOMAIN: The STAS domain mediates dimerization, with both STAS domains CC latched onto each other in a domain-swapped manner (PubMed:35022426). CC The N-terminus domain is involved in dimerization such that each N- CC terminus domain embraces both STAS domains (PubMed:35022426). The STAS CC domain harbors a unique anion-binding site important for the fine CC regulation of the high-frequency electromotile properties (By CC similarity). The transmembrane domain consists of 14 transmembrane CC segments organized a 7(+)7 inverted repeat architecture that can be CC divided into two main helix bundles, the ''core'' domain and the CC ''gate'' domain (PubMed:35022426). The transmembrane regions are CC domain-swapped with the STAS domain containing N- and C-terminal CC cytoplasmic domains (By similarity). The STAS domain mediates CALM CC binding CALM (By similarity). {ECO:0000250|UniProtKB:D7PC76, CC ECO:0000250|UniProtKB:Q9EPH0, ECO:0000269|PubMed:35022426}. CC -!- SIMILARITY: Belongs to the SLC26A/SulP transporter (TC 2.A.53) family. CC {ECO:0000305}. CC -!- WEB RESOURCE: Name=Protein Spotlight; Note=Pump up the volume - Issue CC 22 of May 2002; CC URL="https://web.expasy.org/spotlight/back_issues/022"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF230376; AAF71715.1; -; mRNA. DR PDB; 7SUN; EM; 3.60 A; A/B=1-744. DR PDBsum; 7SUN; -. DR AlphaFoldDB; Q9JKQ2; -. DR SMR; Q9JKQ2; -. DR GlyCosmos; Q9JKQ2; 2 sites, No reported glycans. DR GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB. DR GO; GO:0016328; C:lateral plasma membrane; ISS:UniProtKB. DR GO; GO:0140900; F:chloride:bicarbonate antiporter activity; ISS:UniProtKB. DR GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB. DR GO; GO:0008271; F:secondary active sulfate transmembrane transporter activity; IEA:InterPro. DR GO; GO:0015701; P:bicarbonate transport; ISS:UniProtKB. DR GO; GO:0006821; P:chloride transport; ISS:UniProtKB. DR GO; GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW. DR GO; GO:0007605; P:sensory perception of sound; IEA:UniProtKB-KW. DR CDD; cd07042; STAS_SulP_like_sulfate_transporter; 1. DR Gene3D; 3.30.750.24; STAS domain; 1. DR InterPro; IPR018045; S04_transporter_CS. DR InterPro; IPR011547; SLC26A/SulP_dom. DR InterPro; IPR001902; SLC26A/SulP_fam. DR InterPro; IPR002645; STAS_dom. DR InterPro; IPR036513; STAS_dom_sf. DR NCBIfam; TIGR00815; sulP; 1. DR PANTHER; PTHR11814:SF32; PRESTIN; 1. DR PANTHER; PTHR11814; SULFATE TRANSPORTER; 1. DR Pfam; PF01740; STAS; 1. DR Pfam; PF00916; Sulfate_transp; 1. DR SUPFAM; SSF52091; SpoIIaa-like; 1. DR PROSITE; PS01130; SLC26A; 1. DR PROSITE; PS50801; STAS; 1. PE 1: Evidence at protein level; KW 3D-structure; Cell membrane; Cell shape; Glycoprotein; Hearing; Membrane; KW Motor protein; Transmembrane; Transmembrane helix. FT CHAIN 1..744 FT /note="Prestin" FT /id="PRO_0000080168" FT TOPO_DOM 1..79 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 80..105 FT /note="Helical; Name=1" FT /evidence="ECO:0000269|PubMed:35022426, FT ECO:0007744|PDB:7SUN" FT TOPO_DOM 106..109 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 110..125 FT /note="Helical; Name=2" FT /evidence="ECO:0000269|PubMed:35022426, FT ECO:0007744|PDB:7SUN" FT TOPO_DOM 126..137 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 138..147 FT /note="Helical; Name=3" FT /evidence="ECO:0000269|PubMed:35022426, FT ECO:0007744|PDB:7SUN" FT TOPO_DOM 148..178 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 179..196 FT /note="Helical; Name=4" FT /evidence="ECO:0000269|PubMed:35022426, FT ECO:0007744|PDB:7SUN" FT TOPO_DOM 197..208 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 209..230 FT /note="Helical; Name=5a" FT /evidence="ECO:0000269|PubMed:35022426, FT ECO:0007744|PDB:7SUN" FT TOPO_DOM 231..243 FT /note="Extracellular" FT /evidence="ECO:0000305" FT INTRAMEM 244..252 FT /note="Helical; Name=5b" FT /evidence="ECO:0000269|PubMed:35022426, FT ECO:0007744|PDB:7SUN" FT TOPO_DOM 253..258 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 259..282 FT /note="Helical; Name=6" FT /evidence="ECO:0000269|PubMed:35022426, FT ECO:0007744|PDB:7SUN" FT TOPO_DOM 283..291 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 292..304 FT /note="Helical; Name=7" FT /evidence="ECO:0000269|PubMed:35022426, FT ECO:0007744|PDB:7SUN" FT TOPO_DOM 305..337 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 338..361 FT /note="Helical; Name=8" FT /evidence="ECO:0000269|PubMed:35022426, FT ECO:0007744|PDB:7SUN" FT TOPO_DOM 362..370 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 371..388 FT /note="Helical; Name=9" FT /evidence="ECO:0000269|PubMed:35022426, FT ECO:0007744|PDB:7SUN" FT TOPO_DOM 389..396 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 397..406 FT /note="Helical; Name=10" FT /evidence="ECO:0000269|PubMed:35022426, FT ECO:0007744|PDB:7SUN" FT TOPO_DOM 407..410 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 411..429 FT /note="Helical; Name=11" FT /evidence="ECO:0000269|PubMed:35022426, FT ECO:0007744|PDB:7SUN" FT TOPO_DOM 430..436 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 437..455 FT /note="Helical; Name=12" FT /evidence="ECO:0000269|PubMed:35022426, FT ECO:0007744|PDB:7SUN" FT TOPO_DOM 456..469 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 470..484 FT /note="Helical; Name=13" FT /evidence="ECO:0000269|PubMed:35022426, FT ECO:0007744|PDB:7SUN" FT TOPO_DOM 485 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 486..497 FT /note="Helical; Name=14" FT /evidence="ECO:0000269|PubMed:35022426, FT ECO:0007744|PDB:7SUN" FT TOPO_DOM 498..744 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT DOMAIN 525..713 FT /note="STAS" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00198" FT REGION 505..718 FT /note="Extended region for STAS domain" FT /evidence="ECO:0000250|UniProtKB:Q9EPH0" FT REGION 717..744 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 158..168 FT /note="Involved in motor function" FT /evidence="ECO:0000269|PubMed:22399806" FT BINDING 398 FT /ligand="salicylate" FT /ligand_id="ChEBI:CHEBI:30762" FT /ligand_note="antagonist" FT /evidence="ECO:0000250|UniProtKB:P58743" FT SITE 398 FT /note="Controls the electromotile activity" FT /evidence="ECO:0000250|UniProtKB:A0FKN5, FT ECO:0000250|UniProtKB:Q9EPH0" FT SITE 399 FT /note="Contributes to anion binding" FT /evidence="ECO:0000250|UniProtKB:Q9EPH0" FT CARBOHYD 163 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 166 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT MUTAGEN 398 FT /note="S->E: Removes salicylate competition with anions. FT Retains the displacement currents." FT /evidence="ECO:0000269|PubMed:35022426" FT MUTAGEN 399 FT /note="R->E: Removes salicylate competition with anions. FT Retains the displacement currents." FT /evidence="ECO:0000269|PubMed:35022426" SQ SEQUENCE 744 AA; 81419 MW; 1CDF66589DAACBBC CRC64; MDHAEENEIP VATQKYHVER PIFSHPVLQE RLHVKDKVSE SIGDKLKQAF TCTPKKIRNI IYMFLPITKW LPAYKFKEYV LGDLVSGIST GVLQLPQGLA FAMLAAVPPV FGLYSSFYPV IMYCFFGTSR HISIGPFAVI SLMIGGVAVR LVPDDIVIPG GVNATNGTEA RDALRVKVAM SVTLLSGIIQ FCLGVCRFGF VAIYLTEPLV RGFTTAAAVH VFTSMLKYLF GVKTKRYSGI FSVVYSTVAV LQNVKNLNVC SLGVGLMVFG LLLGGKEFNE RFKEKLPAPI PLEFFAVVMG TGISAGFNLH ESYSVDVVGT LPLGLLPPAN PDTSLFHLVY VDAIAIAIVG FSVTISMAKT LANKHGYQVD GNQELIALGI CNSIGSLFQT FSISCSLSRS LVQEGTGGKT QLAGCLASLM ILLVILATGF LFESLPQAVL SAIVIVNLKG MFMQFSDLPF FWRTSKIELT IWLTTFVSSL FLGLDYGLIT AVIIALLTVI YRTQSPSYKV LGQLPDTDVY IDIDAYEEVK EIPGIKIFQI NAPIYYANSD LYSNALKRKT GVNPALIMGA RRKAMRKYAK EVGNANIANA AVVKVDGEVD GENATKPEEE DDEVKYPPIV IKTTFPEELQ RFMPQTENVH TIILDFTQVN FIDSVGVKTL AVMVKEYGDV GIYVYLAGCS PQVVNDLTRN RFFENPALKE LLFHSIHDAV LGSHVREAMA EQEASAPPPQ DDMEPNATPT TPEA //